Winway Health Desk
Eli Lilly’s Olumiant pares COVID-19 patients’ recovery time down to 7...
Months into the COVID-19 pandemic, just two therapies have emerged as FDA-approved emergency therapies for hospitalized patients. Last month, Eli Lilly rolled out findings...
Pfizer’s Ibrance kisses early breast cancer hopes goodbye with second study...
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show...
3 reasons telehealth is here to stay
Covid-19 has catapulted medicine into a new, virtual world. Although telemedicine has been around for years, it’s quickly transitioned in the last 6 months...
Gilead Sciences’ remdesivir cuts COVID-19 death risk in patients on low-flow...
Gilead Sciences’ remdesivir has been a crucial treatment for COVID-19 for months, but new data from a “gold standard” trial give a clearer picture...
Seattle Genetics rebrands as Seagen as it expands business globally
A rapidly growing biotech company that has won Food and Drug Administration approvals for two new cancer drugs in the space of less than...
Ironwood, AbbVie add ‘bloating’ and ‘discomfort’ to Linzess label to reach...
Ironwood and AbbVie can now add “bloating” and “discomfort” to marketing for irritable bowel syndrome with constipation (IBS-C) drug Linzess, thanks to a supplemental NDA...
Make It Personal
COVID-19 brought to light, in a new way, the exacerbating toll on physical and mental health that frontline workers in healthcare can experience. These...
Startups with tech to improve payer and provider efficiency: Video from...
Healthcare entrepreneurs are an essential part of the innovation landscape and they play center stage at several of MedCity’s events. At MedCity INVEST Digital...
Pharma goes to Hollywood: W2O Group network snaps up veteran influencer...
Pharma companies often turn to celebrities for spokesperson roles, tapping agencies and Hollywood agents to make those connections. But W2O Group now has its...
Pfizer, BioNTech bring on Germany’s Rentschler for purification of mRNA-based coronavirus...
Pfizer and BioNTech are in the home stretch for a late-stage clinical trial of their mRNA-based COVID-19 vaccine, with data expected next month. But...
